Samuel R. Saks, Chief Development Officer at Auspex Pharmaceuticals, Inc. (ASPX), bought 2,175 shares at $12.00 ($26K) on 2014-02-10, disclosed to the SEC on 2014-02-12.
Open-market purchase of $26k ASPX by Chief Development Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| TNXP | BUY | 2015-07-17 | $75K | — | Filing → |
| JAZZ | BUY | 2007-11-15 | $66K | — | Filing → |
| JAZZ | BUY | 2007-11-14 | $318K | — | Filing → |